Cargando…

Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies

OBJECTIVE: This study aimed to 1) identify the frequency of severe and level 2 hypoglycemia presenting in individuals with type 1 diabetes using continuous glucose monitoring systems (CGMs), including those with concomitant closed-loop insulin pumps, in a clinical practice setting and 2) evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yu Kuei, Richardson, Caroline R., Dobrin, Iulia, DeJonckheere, Melissa J., Mizokami-Stout, Kara, Fetters, Michael D., Aikens, James E., Fisher, Simon J., Ye, Wen, Pop-Busui, Rodica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918194/
https://www.ncbi.nlm.nih.gov/pubmed/35015079
http://dx.doi.org/10.2337/dc21-1285
_version_ 1784668681147514880
author Lin, Yu Kuei
Richardson, Caroline R.
Dobrin, Iulia
DeJonckheere, Melissa J.
Mizokami-Stout, Kara
Fetters, Michael D.
Aikens, James E.
Fisher, Simon J.
Ye, Wen
Pop-Busui, Rodica
author_facet Lin, Yu Kuei
Richardson, Caroline R.
Dobrin, Iulia
DeJonckheere, Melissa J.
Mizokami-Stout, Kara
Fetters, Michael D.
Aikens, James E.
Fisher, Simon J.
Ye, Wen
Pop-Busui, Rodica
author_sort Lin, Yu Kuei
collection PubMed
description OBJECTIVE: This study aimed to 1) identify the frequency of severe and level 2 hypoglycemia presenting in individuals with type 1 diabetes using continuous glucose monitoring systems (CGMs), including those with concomitant closed-loop insulin pumps, in a clinical practice setting and 2) evaluate the impact of beliefs around hypoglycemia in the development of severe and level 2 hypoglycemia in this population. RESEARCH DESIGN AND METHODS: A cross-sectional survey study in adults with type 1 diabetes using CGMs >6 months was conducted at a large tertiary academic center. Participant demographics, 6-month severe hypoglycemia history, hypoglycemia beliefs (with the Attitude to Awareness of Hypoglycemia questionnaire), and 4-week CGM glucose data were collected. Statistical analysis was performed to assess the presentation of severe and level 2 hypoglycemia and identify associated risk factors. RESULTS: A total of 289 participants were recruited (including 257 participants with CGM data within the last 3 months). Of these, 25.6% experienced at least one severe hypoglycemic episode in the last 6 months, and 13.6% presented with ≥1% of time in level 2 hypoglycemia on CGMs. Reporting beliefs about prioritizing hyperglycemia avoidance was associated with severe hypoglycemia development (P < 0.001), while having beliefs of minimal concerns for hypoglycemia was associated with spending ≥1% of time in level 2 hypoglycemia (P = 0.038). CONCLUSIONS: Despite the use of advanced diabetes technologies, severe and level 2 hypoglycemia continues to occur in individuals with type 1 diabetes and high hypoglycemia risks. Human factors, including beliefs around hypoglycemia, may continue to impact the effectiveness of glucose self-management.
format Online
Article
Text
id pubmed-8918194
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-89181942022-03-17 Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies Lin, Yu Kuei Richardson, Caroline R. Dobrin, Iulia DeJonckheere, Melissa J. Mizokami-Stout, Kara Fetters, Michael D. Aikens, James E. Fisher, Simon J. Ye, Wen Pop-Busui, Rodica Diabetes Care Clinical Care/Education/Nutrition/Psychosocial Research OBJECTIVE: This study aimed to 1) identify the frequency of severe and level 2 hypoglycemia presenting in individuals with type 1 diabetes using continuous glucose monitoring systems (CGMs), including those with concomitant closed-loop insulin pumps, in a clinical practice setting and 2) evaluate the impact of beliefs around hypoglycemia in the development of severe and level 2 hypoglycemia in this population. RESEARCH DESIGN AND METHODS: A cross-sectional survey study in adults with type 1 diabetes using CGMs >6 months was conducted at a large tertiary academic center. Participant demographics, 6-month severe hypoglycemia history, hypoglycemia beliefs (with the Attitude to Awareness of Hypoglycemia questionnaire), and 4-week CGM glucose data were collected. Statistical analysis was performed to assess the presentation of severe and level 2 hypoglycemia and identify associated risk factors. RESULTS: A total of 289 participants were recruited (including 257 participants with CGM data within the last 3 months). Of these, 25.6% experienced at least one severe hypoglycemic episode in the last 6 months, and 13.6% presented with ≥1% of time in level 2 hypoglycemia on CGMs. Reporting beliefs about prioritizing hyperglycemia avoidance was associated with severe hypoglycemia development (P < 0.001), while having beliefs of minimal concerns for hypoglycemia was associated with spending ≥1% of time in level 2 hypoglycemia (P = 0.038). CONCLUSIONS: Despite the use of advanced diabetes technologies, severe and level 2 hypoglycemia continues to occur in individuals with type 1 diabetes and high hypoglycemia risks. Human factors, including beliefs around hypoglycemia, may continue to impact the effectiveness of glucose self-management. American Diabetes Association 2022-03 2022-01-11 /pmc/articles/PMC8918194/ /pubmed/35015079 http://dx.doi.org/10.2337/dc21-1285 Text en © 2022 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.
spellingShingle Clinical Care/Education/Nutrition/Psychosocial Research
Lin, Yu Kuei
Richardson, Caroline R.
Dobrin, Iulia
DeJonckheere, Melissa J.
Mizokami-Stout, Kara
Fetters, Michael D.
Aikens, James E.
Fisher, Simon J.
Ye, Wen
Pop-Busui, Rodica
Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies
title Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies
title_full Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies
title_fullStr Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies
title_full_unstemmed Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies
title_short Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies
title_sort beliefs around hypoglycemia and their impacts on hypoglycemia outcomes in individuals with type 1 diabetes and high risks for hypoglycemia despite using advanced diabetes technologies
topic Clinical Care/Education/Nutrition/Psychosocial Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918194/
https://www.ncbi.nlm.nih.gov/pubmed/35015079
http://dx.doi.org/10.2337/dc21-1285
work_keys_str_mv AT linyukuei beliefsaroundhypoglycemiaandtheirimpactsonhypoglycemiaoutcomesinindividualswithtype1diabetesandhighrisksforhypoglycemiadespiteusingadvanceddiabetestechnologies
AT richardsoncaroliner beliefsaroundhypoglycemiaandtheirimpactsonhypoglycemiaoutcomesinindividualswithtype1diabetesandhighrisksforhypoglycemiadespiteusingadvanceddiabetestechnologies
AT dobriniulia beliefsaroundhypoglycemiaandtheirimpactsonhypoglycemiaoutcomesinindividualswithtype1diabetesandhighrisksforhypoglycemiadespiteusingadvanceddiabetestechnologies
AT dejonckheeremelissaj beliefsaroundhypoglycemiaandtheirimpactsonhypoglycemiaoutcomesinindividualswithtype1diabetesandhighrisksforhypoglycemiadespiteusingadvanceddiabetestechnologies
AT mizokamistoutkara beliefsaroundhypoglycemiaandtheirimpactsonhypoglycemiaoutcomesinindividualswithtype1diabetesandhighrisksforhypoglycemiadespiteusingadvanceddiabetestechnologies
AT fettersmichaeld beliefsaroundhypoglycemiaandtheirimpactsonhypoglycemiaoutcomesinindividualswithtype1diabetesandhighrisksforhypoglycemiadespiteusingadvanceddiabetestechnologies
AT aikensjamese beliefsaroundhypoglycemiaandtheirimpactsonhypoglycemiaoutcomesinindividualswithtype1diabetesandhighrisksforhypoglycemiadespiteusingadvanceddiabetestechnologies
AT fishersimonj beliefsaroundhypoglycemiaandtheirimpactsonhypoglycemiaoutcomesinindividualswithtype1diabetesandhighrisksforhypoglycemiadespiteusingadvanceddiabetestechnologies
AT yewen beliefsaroundhypoglycemiaandtheirimpactsonhypoglycemiaoutcomesinindividualswithtype1diabetesandhighrisksforhypoglycemiadespiteusingadvanceddiabetestechnologies
AT popbusuirodica beliefsaroundhypoglycemiaandtheirimpactsonhypoglycemiaoutcomesinindividualswithtype1diabetesandhighrisksforhypoglycemiadespiteusingadvanceddiabetestechnologies